BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

D. Li, L. Ambrogio, T. Shimamura, S. Kubo, M. Takahashi, L. R. Chirieac, R. F. Padera, G. I. Shapiro, A. Baum, F. Himmelsbach, W. J. Rettig, M. Meyerson, F. Solca, H. Greulich, K. K. Wong

Research output: Contribution to journalArticlepeer-review

1237 Scopus citations

Fingerprint

Dive into the research topics of 'BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models'. Together they form a unique fingerprint.

Medicine & Life Sciences